Health care stocks were lower Monday afternoon, with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.1%.
The iShares Biotechnology ETF (IBB) retreated 0.1%.
In corporate news, Novo Nordisk (NVO) shares fell 9% after the latest trial results of the Danish drugmaker's investigative weight loss drug, CagriSema, trailed its own initial expectations.
Checkpoint Therapeutics (CKPT) shares were rising nearly 62% after the firm and India's Sun Pharmaceutical said Sunday that Checkpoint has agreed to be acquired by Sun for $4.10 a share in cash plus a non-transferable contingent value right.
BioNTech (BNTX) reported a decline in Q4 revenue and projected full-year sales to fall again in 2025. Its shares fell 2.6%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。